Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
12.85
-0.36 (-2.73%)
Nov 21, 2024, 11:18 AM EST - Market open
Sotera Health Company Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SHC stock have an average target of 16.5, with a low estimate of 13 and a high estimate of 20. The average target predicts an increase of 28.40% from the current stock price of 12.85.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHC stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +55.64% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +32.30% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +32.30% | Aug 6, 2024 |
| Piper Sandler | Piper Sandler | Hold Initiates $13 | Hold | Initiates | $13 | +1.17% | May 21, 2024 |
| Barclays | Barclays | Buy Maintains $19 → $14 | Buy | Maintains | $19 → $14 | +8.95% | Apr 10, 2024 |
Financial Forecast
Revenue This Year
1.11B
from 1.05B
Increased by 6.17%
Revenue Next Year
1.18B
from 1.11B
Increased by 6.10%
EPS This Year
0.71
from 0.18
Increased by 296.00%
EPS Next Year
0.82
from 0.71
Increased by 15.05%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.2B | 1.2B | 1.3B | ||
| Avg | 1.1B | 1.2B | 1.3B | ||
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.7% | 11.3% | 12.7% | ||
| Avg | 6.2% | 6.1% | 6.8% | ||
| Low | 2.4% | 1.8% | 2.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.76 | 0.88 | 1.05 |
| Avg | 0.71 | 0.82 | 0.96 |
| Low | 0.67 | 0.74 | 0.87 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 321.2% | 23.1% | 27.6% |
| Avg | 296.0% | 15.1% | 16.7% |
| Low | 270.2% | 4.5% | 6.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.